FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Shamrock Medical Solutions Group Docusate Calcium Softgel Capsules Recall

Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusat…

Shamrock Medical Solutions Group LLC · Lewis Center, OH

Risk level
Class II
Reported by FDA
Jul 30, 2014
Recall ID
D-1451-2014
Check your lot numberHow we source this data

Summary

Shamrock Medical Solutions Group recalled Docusate Calcium Softgel Capsules starting Sep 27, 2011. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1451-2014 on Jul 30, 2014. Reason: Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calcium 240mg. Status: Terminated.

Why it was recalled

Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calcium 240mg

Product description

Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Major Pharmaceuticals, Livonia, MI NDC 00904-5779-60

Lot numbers, UPCs & expiration codes

Lot #: 002H79, Use By: 06/19/2013, NDC: 00904-5779-60

Where it was sold

Product was shipped to the following states: CO, MA, OH, TX & WY.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1451-2014
Classification
Class II
Status
Terminated
Recall initiated
Sep 27, 2011
FDA report date
Jul 30, 2014
Quantity
99/240 mg softgel caps
Recall type
Voluntary: Firm initiated
Recalling firm
Shamrock Medical Solutions Group LLC

Original FDA data

Every field from FDA enforcement report D-1451-2014, exactly as published.

Show all FDA fields
City
Lewis Center
State
OH
Status
Terminated
Country
United States
Event ID
64611
Address
741 Radio Dr
Code information
Lot #: 002H79, Use By: 06/19/2013, NDC: 00904-5779-60
Postal code
43035-7134
Report date
Jul 30, 2014
Product type
Drugs
Recall number
D-1451-2014
Classification
Class II
Recalling firm
Shamrock Medical Solutions Group LLC
Product quantity
99/240 mg softgel caps
Termination date
Jul 31, 2014
Reason for recall
Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calcium 240mg
Voluntary / mandated
Voluntary: Firm initiated
Product description
Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Major Pharmaceuticals, Livonia, MI NDC 00904-5779-60
Distribution pattern
Product was shipped to the following states: CO, MA, OH, TX & WY.
Recall initiation date
Sep 27, 2011
Initial firm notification
Telephone
Center classification date
Jul 23, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1451-2014, published Jul 30, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls